Alerta

Network topology for insulin pump systems

Resumen de: AU2025203909A1

A controller in an insulin delivery system for the delivery of insulin to a patient, the controller configured to control operation of an insulin delivery device, the controller comprising: a chipset for establishing communications with a glucose monitor and a smartphone; one or more processors; and computer memory storing instructions that, when executed by the one or more processors, cause the one or more processors to: establish, using the chipset, a first network connection with the glucose monitor; establish, using the chipset, a second network connection with the smartphone, the smartphone running a mobile application, wherein the mobile application is executed by the smartphone; receive, via the first network connection, patient data related to blood glucose levels from the glucose monitor; transmit, via the second network connection, the patient data related to blood glucose levels to the smartphone; and receive, from the smartphone via the second network connection, an instruction to administer an insulin dosage, wherein the instruction to administer the insulin dosage is initiated by the mobile application running on the smartphone, and wherein the insulin dosage is based at least in part on the patient data related to blood glucose levels transmitted to the smartphone; and transmit, to the smartphone via the second network connection, a communication verifying that the administration of the insulin dosage has been completed.

Analyte sensors and sensing methods featuring dual detection of glucose and ketones

Resumen de: AU2025203882A1

Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.

EXERCISE MANAGEMENT METHOD AND SYSTEM FOR MANAGING BLOOD SUGAR VARIABILITY

Resumen de: WO2025127627A1

The present invention relates to an exercise management method and system for managing blood sugar variability. The method according to the present invention comprises the steps of: obtaining data on the timing of postprandial blood sugar spikes on the basis of a user's blood sugar data acquired during a first period; calculating an optimal start time for postprandial aerobic exercise on the basis of the data on the timing of postprandial blood sugar spikes; and providing an alert for the start time of postprandial aerobic exercise on the basis of the optimal start time for postprandial aerobic exercise during a second period. According to the present invention, it is possible to recommend an effective postprandial aerobic exercise time tailored to a user's blood sugar pattern. In addition, it is possible to prompt a user to start aerobic exercise at the optimal time point for postprandial aerobic exercise according to the meal. Furthermore, by analyzing and providing the improvement in blood sugar levels of postprandial aerobic exercise, the user's will to perform postprandial aerobic exercise can be encouraged and adherence to exercise can be enhanced.

INSULIN NEEDLE TIP PROTECTION MECHANISM AND INSULIN INJECTION DEVICE

Resumen de: EP4570286A1

This invention discloses a protective mechanism for insulin needles and an insulin injection device. Through the cooperation of a U-shaped reciprocating slot and a flexible wall, it is possible to automatically retract the needle tip after injection, and prevent it from being pushed out again, thus achieving the purpose of needle tip protection and avoiding reuse.

PCLED LIGHT SOURCE AND SWIR SPECTROMETER FOR NONINVASIVE TISSUE GLUCOSE SELF-MONITORING

Nº publicación: EP4569046A1 18/06/2025

Solicitante:

LUMILEDS LLC [US]
Lumileds LLC

Resumen de: US2025152053A1

A glucose measurement device comprising a light emitting device comprising an SWIR phosphor having emission wavelengths in the range of 1600-2200 nm, the SWIR phosphor comprising a structurally disordered garnet material, a sensitizer ion, and at least one rare earth emitter ion, and a infrared light detector arranged to detect the intensity of short wavelength infrared light emitted by the light emitting device and reflected by a sample. The emission spectra provided by the light emitting device having a high temperature stability at infrared absorption minima and maxima wavelengths of glucose in tissue.